Somlyay, M; Durinikova, E; Besnard, J; Barbeau, O; Le Coz, J; Senekowitsch, M; Erguner, B; Hackner, K; Dzurillova, L; Petru, E; Lafleur, J; Singer, J; Fureder, T; Paveley, R; Joseph, J; Aswad, F; Winkler-Penz, T; Sehlke, R; Boudesco, C; Vladimer, G.
Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling
EUR J CANCER. 2022; 174: S44-S45.
[Poster]
Web of Science